Generic Pharmaceutical

Indications:

The drug is used in:

• Iridocyclitis (for prevention of posterior synechia and reduce exudation from the iris).
• Diagnostic pupil dilation with ophthalmoscopy and other diagnostic procedures required for control of posterior segment eye.
• Carrying out a provocative test in patients with a narrow profile and the anterior chamber angle-closure glaucoma suspected.
• Differential diagnosis of superficial and deep injections of the eyeball.
• Expanding the pupil during the laser interventions in the fundus and vitreoretinal surgery.
• Treatment of glaucoma-cyclic crises.
• In the treatment of syndrome of "red eye" 2,5% Irifrin ® solution can help reduce irritation, hyperemia of eye tissues.
• Spasm of accommodation.

Dosage and administration:
In conducting ophthalmoscopy one instillation of 2.5% solution of Irifrin® is used. Typically, to create mydriasis introduction of 1 drop of 2.5% of Irifrin ® into conjunctival sac is sufficient.
Maximal mydriasis is achieved in15-30 minutes, and remains at sufficient level for 1-3 hours.
In the case of the need to maintain mydriasis for longer time, repeated instillation of Irifrin ® in1 hour after first instillation is possible.
To remove the spasm of accommodation in children 6 years and adults 2.5% solution of Irifrin ® 1 drop in each eye at night every day for 4 weeks is recommended .
For diagnostic procedures single instillation of 2.5% solution of Irifrin® is used:

• as a provocative test in patients with a narrow profile anterior chamber angle and suspicion for closure glaucoma. If difference between the values of intraocular pressure before instillation of Irifrin ® and after dilatation of pupils ranges from 3 to 5 mm Hg., then a provocative test considered positive;
• for differential diagnosis of eye apple injection type: If after 5 minutes instillation marked narrowing vessels of the eyeball, the injection classified as superficial. While maintaining the eyes reddening patients should be carefully examined for the presence of iridocyсlitis or sclerites, as it demonstrates dilatation of more deep-lying vessels.

In iridocyclitis 2.5% Irifrin® solution is used to prevent the development and rupture of already formed posterior synechia; to reduce the exudation in the anterior chamber of the eye. For this purpose, 1 drop of drug instilled in conjunctival sac of the patient eye (eyes) 2-3 times a day.